Preclinical evaluation and molecular docking of 1,3-benzodioxole propargyl ether derivatives as novel inhibitor for combating the histone deacetylase enzyme in cancer.
about
Preclinical evaluation and molecular docking of 1,3-benzodioxole propargyl ether derivatives as novel inhibitor for combating the histone deacetylase enzyme in cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Preclinical evaluation and mol ...... deacetylase enzyme in cancer.
@en
Preclinical evaluation and mol ...... deacetylase enzyme in cancer.
@nl
type
label
Preclinical evaluation and mol ...... deacetylase enzyme in cancer.
@en
Preclinical evaluation and mol ...... deacetylase enzyme in cancer.
@nl
prefLabel
Preclinical evaluation and mol ...... deacetylase enzyme in cancer.
@en
Preclinical evaluation and mol ...... deacetylase enzyme in cancer.
@nl
P2093
P2860
P1476
Preclinical evaluation and mol ...... e deacetylase enzyme in cancer
@en
P2093
Apurva Pandey
Neeraj Kumar
Ramesh Chandra
Ravi Tomar
Vartika Tomar
P2860
P304
P356
10.1080/21691401.2017.1369423
P577
2017-08-28T00:00:00Z